Houston C A, Cleary M, Dutton G N, McFadzean R M
Orthoptic Department, Glasgow Eye Infirmary.
Br J Ophthalmol. 1998 Mar;82(3):219-24. doi: 10.1136/bjo.82.3.219.
BACKGROUND/AIMS: Microtropia is believed to be a static condition, in which accepted achievable levels of vision are those of 6/12-6/9 maximum, with the inability to achieve "normal" levels of stereopsis. The aim of this paper was to present the results of treatment of 30 consecutively presenting primary microtropes, and assess their outcomes using a more active treatment strategy than that conventionally used.
Visual acuity, stereoacuity, fixation, and the presence of a central suppression scotoma were assessed in all patients before, during, and after treatment, which comprised wearing maximum refractive correction, and an occlusion strategy aiming for equal visual acuity.
Equal visual acuity of 6/5 Snellen was achieved in 43% of the 30 patients, while 87% achieved 6/9 Snellen or better visual acuity in the microtropic eye. Stereoacuity of better than 60" of arc was attained in 37%, and foveal fixation on visuscopy in 55%. The treatment outcome was not affected by the patient's age, initial visual acuity, or the amount of anisometropia. A change in the patient's diagnosis was noted in 50%, with nine patients recovering completely.
The results show that microtropia is not static. Equal 6/5 vision is attainable, as is high grade stereoacuity. The pattern of fixation may change during treatment and elimination of the microtropia is possible in some cases. There is a requirement for management protocols to be changed in order to treat this condition more effectively.
背景/目的:微小斜视被认为是一种静止性病症,其可接受的最佳视力水平最高为6/12 - 6/9,无法达到“正常”的立体视水平。本文旨在呈现连续30例原发性微小斜视患者的治疗结果,并采用比传统方法更积极的治疗策略评估其疗效。
在所有患者治疗前、治疗期间及治疗后评估视力、立体视、注视以及中心抑制暗点的存在情况,治疗包括佩戴最大屈光矫正眼镜以及旨在获得同等视力的遮盖策略。
30例患者中有43%达到了6/5 Snellen的同等视力,而87%的微小斜视眼达到了6/9 Snellen或更好的视力。37%的患者立体视优于60角秒,55%的患者在视力检查时中央凹注视。治疗结果不受患者年龄、初始视力或屈光参差量的影响。50%的患者诊断发生了变化,9例患者完全康复。
结果表明微小斜视并非静止不变。可以实现6/5的同等视力以及高级别的立体视。注视模式在治疗过程中可能会改变,某些情况下消除微小斜视是可能的。需要改变管理方案以更有效地治疗这种病症。